Transcriptomics and optogenetics for lipid expression (togle)
Other Transaction IDV Awarded Last action
- Contract number
- HR00112590060
- Awardee
-
Capra Biosciences Inc. UEI UMYRLBCXW9T5
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Task orders
- 0
Award facts
- Last date to order
- Not on record
- IDV ceiling
- $13,053,736.00
- Contracting staff
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Program Solicitation
- Pricing
- Other
Award details come from SAM.gov/FPDS.
About this IDV
DARPA awarded a multiple-award Other Transaction IDV to Capra Biosciences Inc. with a ceiling of $13,053,736 on January 21, 2024, outside the FAR framework. The IDV supports Phase 1 funding for the Biological Technologies Office SWITCH program focused on transcriptomics and optogenetics for lipid expression (TOGLE).
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $1,148,721 | |
| Funding Only Action | $1,621,072 | |
| Funding Only Action | $42,237 | |
| Additional Work (new agreement, FAR part 6 applies) | $1,565,670 | |
| Other Administrative Action | $0 | |
| Original award | $293,904 |
Quick answers
Who was awarded contract HR00112590060?
HR00112590060 was awarded to Capra Biosciences Inc. by Defense Advanced Research Projects Agency (Department of Defense) on January 21, 2024.
How much is contract HR00112590060 worth?
HR00112590060's own ceiling is $13,053,736.
Was contract HR00112590060 competed?
The extent of competition for HR00112590060 was competed.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV